Dolphin Bioresearch Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-12-2024
- Paid Up Capital ₹ 1.00 M
as on 15-12-2024
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.95 M
as on 15-12-2024
About Dolphin Bioresearch
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹9.95 M.
Mukeshkumar Chovatiya and Sonalben Chovatiya serve as directors at the Company.
- CIN/LLPIN
U73100GJ2020PTC115155
- Company No.
115155
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jul 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dolphin Bioresearch?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukeshkumar Chovatiya  | Director | 31-Jul-2020 | Current |
| Sonalben Chovatiya | Director | 31-Jul-2020 | Current |
Financial Performance of Dolphin Bioresearch.
Enhance accessibility to Dolphin Bioresearch's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dolphin Bioresearch?
Unlock access to Dolphin Bioresearch's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Vaidik Ayurved Research Private LimitedActive 4 years 4 months
Mukeshkumar Chovatiya is a mutual person
- Dolphin Scientific (India) Private LimitedActive 10 years 6 days
Mukeshkumar Chovatiya is a mutual person
- Dolphin Embro India Private LimitedActive 13 years 7 months
Mukeshkumar Chovatiya is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Jan 2021 | ₹9.95 M | Open |
How Many Employees Work at Dolphin Bioresearch?
Dolphin Bioresearch has a workforce of 0 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dolphin Bioresearch, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dolphin Bioresearch's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
